Literature DB >> 24876234

Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys.

Susan E Martelle1, Susan H Nader1, Paul W Czoty1, William S John1, Angela N Duke1, Pradeep K Garg1, Sudha Garg1, Amy H Newman1, Michael A Nader2.   

Abstract

The dopamine (DA) D3 receptor (D3R) has been associated with impulsivity, pathologic gambling, and drug addiction, making it a potential target for pharmacotherapy development. Positron emission tomography studies using the D3R-preferring radioligand [(11)C]PHNO ([(11)C](+)-propyl-hexahydro-naphtho-oxazin) have shown higher binding potentials in drug abusers compared with control subjects. Preclinical studies have examined D3R receptor activation using the DA agonist quinpirole and the unconditioned behavior of yawning. However, the relationship between quinpirole-elicited yawning and D3R receptor availability has not been determined. In Experiment 1, eight drug-naive male rhesus monkeys were scanned with [(11)C]PHNO, and the ability of quinpirole (0.01-0.3 mg/kg i.m.) to elicit yawning was examined. Significant positive (globus pallidus) and negative (caudate nucleus, putamen, ventral pallidum, and hippocampus) relationships between D3R receptor availability and quinpirole-induced yawns were noted. Experiment 2 replicated earlier findings that a history of cocaine self-administration (n = 11) did not affect quinpirole-induced yawning and extended this to examine monkeys (n = 3) with a history of methamphetamine (MA) self-administration and found that monkeys with experience self-administering MA showed greater potency and significantly higher quinpirole-elicited yawning compared with controls. Finally, quinpirole-elicited yawning was studied in drug-naive female monkeys (n = 6) and compared with drug-naive male monkeys (n = 8). Sex differences were noted, with quinpirole being more potent and eliciting significantly more yawns in males compared with females. Taken together these findings support the use of quinpirole-elicited yawning as a behavioral tool for examining D3R activation in monkeys and that both drug history and sex may influence individual sensitivity to the behavioral effects of D3R compounds. U.S. Government work not protected by U.S. copyright.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24876234      PMCID: PMC4109495          DOI: 10.1124/jpet.114.214833

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  65 in total

1.  Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior.

Authors:  Janet L Neisewander; Rita A Fuchs; Ly T L Tran-Nguyen; Suzanne M Weber; Greg P Coffey; Jeffrey N Joyce
Journal:  Neuropsychopharmacology       Date:  2004-08       Impact factor: 7.853

Review 2.  Gender differences in dopaminergic function in striatum and nucleus accumbens.

Authors:  J B Becker
Journal:  Pharmacol Biochem Behav       Date:  1999-12       Impact factor: 3.533

Review 3.  Biological basis of sex differences in drug abuse: preclinical and clinical studies.

Authors:  Wendy J Lynch; Megan E Roth; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2002-09-05       Impact factor: 4.530

4.  Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.

Authors:  S R Letchworth; M A Nader; H R Smith; D P Friedman; L J Porrino
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

5.  Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats.

Authors:  C T Dourish; P H Hutson
Journal:  Neuropharmacology       Date:  1985-11       Impact factor: 5.250

6.  Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; Y S Ding; M Sedler; J Logan; D Franceschi; J Gatley; R Hitzemann; A Gifford; C Wong; N Pappas
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

7.  Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice.

Authors:  Bernard Le Foll; Henriette Francès; Jorge Diaz; Jean-Charles Schwartz; Pierre Sokoloff
Journal:  Eur J Neurosci       Date:  2002-06       Impact factor: 3.386

8.  Apomorphine-induced penile erection and yawning: site of action in brain.

Authors:  M R Melis; A Argiolas; G L Gessa
Journal:  Brain Res       Date:  1987-07-07       Impact factor: 3.252

Review 9.  Sex differences in pharmacokinetics and pharmacodynamics.

Authors:  Monica Gandhi; Francesca Aweeka; Ruth M Greenblatt; Terrence F Blaschke
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

Review 10.  Substance use disorders: sex differences and psychiatric comorbidities.

Authors:  Monica L Zilberman; Hermano Tavares; Sheila B Blume; Nady el-Guebaly
Journal:  Can J Psychiatry       Date:  2003-02       Impact factor: 4.356

View more
  10 in total

1.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

2.  Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.

Authors:  Kathryn Lanza; Katherine Chemakin; Sarah Lefkowitz; Carolyn Saito; Nicole Chambers; Christopher Bishop
Journal:  Psychopharmacology (Berl)       Date:  2019-08-21       Impact factor: 4.530

3.  Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys.

Authors:  William S John; Amy Hauck Newman; Michael A Nader
Journal:  Neuropharmacology       Date:  2015-01-06       Impact factor: 5.250

4.  Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm.

Authors:  William S John; Ashwini K Banala; Amy H Newman; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2014-10-21       Impact factor: 4.530

5.  Yawning elicited by intravenous ethanol in rhesus monkeys with experience self-administering cocaine and ethanol: Involvement of dopamine D3 receptors.

Authors:  Paul W Czoty; William S John; Amy Hauck Newman; Michael A Nader
Journal:  Alcohol       Date:  2017-10-17       Impact factor: 2.405

6.  2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.

Authors:  Amy Hauck Newman; Francisco O Battiti; Alessandro Bonifazi
Journal:  J Med Chem       Date:  2019-09-24       Impact factor: 7.446

7.  Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Authors:  Thomas M Keck; William S John; Paul W Czoty; Michael A Nader; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-03-31       Impact factor: 7.446

8.  The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats.

Authors:  Gregory L Powell; Mark D Namba; Annika Vannan; John Paul Bonadonna; Andrew Carlson; Rachel Mendoza; Peng-Jen Chen; Robert R Luetdke; Benjamin E Blass; Janet L Neisewander
Journal:  Biomolecules       Date:  2020-07-18

9.  Evaluation of dopamine D3 receptor occupancy by blonanserin using [11C]-(+)-PHNO in schizophrenia patients.

Authors:  Takeshi Sakayori; Amane Tateno; Ryosuke Arakawa; Woo-Chan Kim; Yoshiro Okubo
Journal:  Psychopharmacology (Berl)       Date:  2020-11-12       Impact factor: 4.530

10.  Effects of chronic cocaine and ethanol self-administration on brain dopamine receptors in a rhesus monkey model of polysubstance abuse.

Authors:  Felicity M Say; Aaron M Tryhus; Phillip M Epperly; Susan H Nader; Kiran K Solingapuram Sai; Brianna E George; Haley A Kirse; Paul W Czoty
Journal:  Addict Biol       Date:  2022-09       Impact factor: 4.093

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.